BioHarvest Sciences Inc.
BHST
$11.04
-$0.99-8.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.08M | -2.34M | -2.96M | -2.69M | -687.00K |
| Total Depreciation and Amortization | 407.00K | 399.00K | 341.00K | 351.00K | 357.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.87M | 501.00K | 605.00K | 603.00K | -972.00K |
| Change in Net Operating Assets | 343.00K | 11.00K | -379.00K | -24.00K | 344.00K |
| Cash from Operations | -1.46M | -1.43M | -2.39M | -1.76M | -958.00K |
| Capital Expenditure | -592.00K | -684.00K | -393.00K | -512.00K | -1.71M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 4.00K | -7.00K | 40.00K | -225.00K |
| Cash from Investing | -592.00K | -680.00K | -400.00K | -472.00K | -1.93M |
| Total Debt Issued | 2.64M | 3.34M | 3.31M | -- | -- |
| Total Debt Repaid | -256.00K | -221.00K | -860.00K | -164.00K | -119.00K |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 4.73M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.39M | 3.12M | 2.45M | -164.00K | 4.61M |
| Foreign Exchange rate Adjustments | -12.00K | -4.00K | -43.00K | -5.00K | 17.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 326.00K | 1.01M | -378.00K | -2.40M | 1.73M |